Santoro E, Carboni M, Catarci M, Carlini M, Carboni F, Zupi G, Vecchione A, D'Agnano I, Giannarelli D, Santoro R, Garofalo A
Second Department of Oncologic Surgery, Regina Elena Cancer Institute.
Hepatogastroenterology. 1997 May-Jun;44(15):826-37.
BACKGROUND/AIMS: The purpose of this study was to define the prognostic role of DNA ploidy, proliferative index and EGF-R status in resected gastric cancer.
Ten clinico-pathological parameters and three biological factors obtained from flow cytometry and immunohisto-chemistry were evaluated in a series of 130 gastric cancer patients who received surgical treatment, including 28 stage IV cases (21.6%), using paraffin-embedded and fresh specimens in 77.7% and 22.3% of the cases, respectively. These variables were first analyzed and tested for correlation within the whole series and then weighted against survival in 117 applicable cases through univariate and multivariate analyses.
Aneuploidy was significantly related to higher proliferative activity, EGF-R expression and deeper stomach wall infiltration. Higher proliferative activity was significantly related to deeper stomach wall infiltration and larger tumor diameter. The latter showed a significant relationship to EGF-R expression. Univariate analysis showed the significant variables for survival to be DNA ploidy, pT, pN, M, stage, histological type according to Lauren and tumor diameter. Multivariate analysis calculated on these significant variables using the Cox multiple stepwise regression model detected three factors which independently influence survival: pathological stage (p < 0.00001), histological type according to Lauren (p < 0.002) and DNA ploidy (p < 0.03).
DNA ploidy was shown to be a significant prognostic parameter in resected gastric cancer after pathological stage and histological type according to Lauren. The prognostic roles of proliferative activity and EGF-R status require further investigation.
背景/目的:本研究旨在明确DNA倍体、增殖指数和表皮生长因子受体(EGF-R)状态在胃癌切除术后的预后作用。
对130例接受手术治疗的胃癌患者进行评估,这些患者包括28例IV期病例(21.6%),从其石蜡包埋和新鲜标本中分别获取了10个临床病理参数以及通过流式细胞术和免疫组织化学获得的3个生物学因素,其中77.7%的病例使用石蜡包埋标本,22.3%的病例使用新鲜标本。首先对这些变量在整个系列中进行相关性分析和检验,然后通过单因素和多因素分析,在117例适用病例中对这些变量与生存率进行加权分析。
非整倍体与较高的增殖活性、EGF-R表达及胃壁浸润深度显著相关。较高的增殖活性与胃壁浸润深度及肿瘤直径较大显著相关。肿瘤直径较大与EGF-R表达显著相关。单因素分析显示,影响生存的显著变量为DNA倍体、pT、pN、M、分期、Lauren组织学类型及肿瘤直径。使用Cox多步回归模型对这些显著变量进行多因素分析,检测到三个独立影响生存的因素:病理分期(p<0.00001)、Lauren组织学类型(p<0.002)及DNA倍体(p<0.03)。
在根据Lauren分类的病理分期和组织学类型之后,DNA倍体被证明是胃癌切除术后一个显著的预后参数。增殖活性和EGF-R状态的预后作用需要进一步研究。